Research Centres for Clinical Treatment (FKBs) are to carry out frontline research to improve treatment for Norwegian patients. One of Matrix's primary research tasks is therefore to conduct clinical trials open for patients with hard-to-treat cancers. Patients throughout the country will be given the opportunity to take part in these studies.
Her vil det i fremtiden linkes til pågående kliniske studier
The overall ambition of Matrix is to extend the lives and improve the quality of life of patients with hard-to-treat cancers. The Centre will actively involve patients in treatment decisions, and user participation in research is very important for Matrix. In particular, patient involvement is important in work package three and five. Here, the team will develop and implement digital patient-centred care pathways, where content and follow-up of the patient is adapted to each individual. Input from patients will therefore be essential here.
The purpose of user participation in research is to improve the relevance of the research by ensuring that the users' perspective, experiences and needs are reflected in the research. Matrix will establish a patient committee, and user representatives from this committee will interact with the various working groups and Centre management on a regular basis. In addition, the Matrix Board has members representing patient organizations.